Search Results

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial.

• Authors : King, Brett (AUTHOR); Zhang, Xingqi (AUTHOR); Harcha, Walter Gubelin (AUTHOR)

Subjects: PFIZER Inc.; ALOPECIA areata; ADULTS

• Source: Lancet. May2023, Vol. 401 Issue 10387, p1518-1529. 12p.

Record details

Is alopecia areata an autoimmune disease?

• Authors : Randall, Valerie Anne

Subjects: ALOPECIA areata; HAIR diseases; AUTOIMMUNE diseases

• Source: Lancet. 12/8/2001, Vol. 358 Issue 9297, p1922. 3p. 1 Diagram.

Record details

Clinical picture.

• Authors : Piguet, Vincent; Friedli, André; Pessina, Pierre-Alain

Subjects: GIANT cell arteritis; ALOPECIA areata; DISEASES

• Source: Lancet. 4/6/2002, Vol. 359 Issue 9313, p1199. 1/3p. 1 Color Photograph.

Record details

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I).

• Authors : Morand, Eric F (AUTHOR); Vital, Edward M (AUTHOR); Petri, Michelle (AUTHOR)

Subjects: ELI Lilly & Co.; SYSTEMIC lupus erythematosus; CLINICAL trials

• Source: Lancet. Mar2023, Vol. 401 Issue 10381, p1001-1010. 10p.

Record details

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).

• Authors : Petri, Michelle (AUTHOR); Bruce, Ian N (AUTHOR); Dörner, Thomas (AUTHOR)

Subjects: ELI Lilly & Co.; SYSTEMIC lupus erythematosus; CLINICAL trials

• Source: Lancet. Mar2023, Vol. 401 Issue 10381, p1011-1019. 9p.

Record details

New treatments for alopecia areata.

• Authors : Lebwohl, Mark

Subjects: IMMUNOTHERAPY; PSORALENS; ALOPECIA areata

• Source: Lancet. 1/25/1997, Vol. 349 Issue 9047, p222. 2p. 2 Color Photographs.

Record details

JAK inhibitors and alopecia areata.

• Authors : Gilhar, Amos; Keren, Aviad; Paus, Ralf

• Source: Lancet. 1/26/2019, Vol. 393 Issue 10169, p318-319. 2p.

Record details

Germany's cyproterone warning.

Subjects: GERMANY. Federal Agency for Drugs & Medical Devices; PHARMACEUTICAL policyGERMANY

• Source: Lancet. 4/15/1995, Vol. 345 Issue 8955, p979. 1/9p.

Record details

Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

• Authors : Meggitt SJ (AUTHOR); Gray JC (AUTHOR); Reynolds NJ (AUTHOR)

• Source: Lancet. 3/11/2006, Vol. 367 Issue 9513, p839-846. 8p.

Record details

Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial.

• Authors : Seaton ED (AUTHOR); Charakida A (AUTHOR); Mouser PE (AUTHOR)

• Source: Lancet. 10/25/2003, Vol. 362 Issue 9393, p1347-1352. 6p.

Record details